Data insights 14 August 2024 Pfizer takes on Merck in a new checkpoint Pfizer’s LILRB1 x LILRB2 bispecific is about to enter the clinic. Read more
Data insights 13 May 2024 Lilly joins the folate receptor arena Lilly’s Mablink acquisition challenges Genmab’s move for ProfoundBio. Read more